ヒト初代細胞培養の世界市場レポート 2025年

ヒト初代細胞培養市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR11.3％で58億2,000万米ドルに成長します。予測期間中の成長は、再生医療への投資の増加、精密医療への利用の増加、細胞ベースの研究に対する政府資金の増加、政府支援の強化、毒物検査におけるヒト初代細胞培養の利用拡大などに起因しています。予測期間中に予想される主な動向には、細胞培養分析における人工知能（AI）の統合、無血清培地や化学的に定義された培地の開発、細胞培養プロセスの自動化の進展、organ-on-a-chip技術の出現、免疫療法研究における初代細胞の需要拡大などがあります。

細胞療法と遺伝子療法への注目の高まりが、ヒト初代細胞培養市場の拡大を牽引すると予測されています。細胞・遺伝子治療は、遺伝物質や細胞を改変・置換し、疾患の分子的根源に対処する最先端の治療法です。このような関心が高まっている背景には、遺伝性疾患、希少疾患、がんなどの根本的な原因をターゲットにすることで、長期にわたる、あるいは根治的な解決策を提供することが期待されていることがあります。ヒト初代細胞培養は、これらの治療法の開発、ウイルスベクターの製造、遺伝子編集アプローチの試験において重要な役割を果たしています。例えば、2024年7月、米国の非営利団体である米国遺伝子・細胞治療学会（ASGCT）は、第2四半期に米国で76件の遺伝子治療臨床試験が開始されたと報告しました。その結果、細胞療法と遺伝子療法への注目が高まり、ヒト初代細胞培養市場の成長が加速しています。

iPS細胞やESC技術は、成体細胞や胚性細胞を多能性状態に初期化することで、科学研究、治療開発、疾患モデリングに使用する様々な細胞タイプへの分化を可能にします。例えば、2024年7月、インドのライフサイエンス・バイオテクノロジー企業であるBioServe Biotechnologies India Pvt Ltd.は、インドでの研究や創薬をサポートするため、REPROCELLの先進幹細胞製品群を新たに導入しました。これらの製品には、特殊な細胞培養培地、幹細胞分化キット、3D培養システム、創薬ツールなどが含まれ、iPS細胞やESCのイノベーションによって再生医療や前臨床研究を促進します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界ヒト初代細胞培養PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のヒト初代細胞培養市場：成長率分析
• 世界のヒト初代細胞培養市場の実績：規模と成長, 2019-2024
• 世界のヒト初代細胞培養市場の予測：規模と成長, 2024-2029, 2034F
• 世界ヒト初代細胞培養総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のヒト初代細胞培養市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 一次細胞
• 試薬とサプリメント
• 機器
• 一次細胞培養培地
• その他の消耗品
• 世界のヒト初代細胞培養市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 創薬
• 治療法の開発
• 再生医療
• その他の用途
• 世界のヒト初代細胞培養市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 製薬およびバイオテクノロジー企業
• 契約調査機関（CRO）
• 学術調査機関
• 世界のヒト初代細胞培養市場一次細胞の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ヒト真皮線維芽細胞（HDF）
• ヒト表皮ケラチノサイト（HEK）
• ヒト間葉系幹細胞（HMSC）
• ヒト内皮細胞
• ヒト造血細胞
• 世界のヒト初代細胞培養市場試薬およびサプリメントの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 成長因子とサイトカイン
• 抗生物質と抗真菌薬
• 牛胎児血清（FBS）
• 緩衝剤と化学物質
• 凍結保存試薬
• 世界のヒト初代細胞培養市場、楽器の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 細胞培養インキュベーター
• バイオセーフティキャビネット
• 遠心分離機
• 細胞カウンターと分析装置
• 顕微鏡
• 世界のヒト初代細胞培養市場一次細胞培養培地の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 無血清培地
• 化学的に定義された培地
• 古典メディア
• 無タンパク質培地
• カスタムメディア
• 世界のヒト初代細胞培養市場その他の消耗品の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 文化皿とプレート
• フラスコとボトル
• ピペットとチップ
• 細胞ストレーナーとフィルター
• コーティングされた培養表面

第7章 地域別・国別分析

• 世界のヒト初代細胞培養市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のヒト初代細胞培養市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ヒト初代細胞培養市場：競合情勢
• ヒト初代細胞培養市場：企業プロファイル
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
  • STEMCELL Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • American Type Culture Collection Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• PromoCell GmbH
• Krishgen Biosystems Private Limited
• Cell Culture Company Limited Liability Company
• HiMedia Laboratories Private Limited
• 3H Biomedical Aktiebolag
• ScienCell Research Laboratories Inc.
• Cell Applications Incorporated
• Life Technologies Private Limited
• PELOBIOTECH Gesellschaft mit beschrankter Haftung
• Amsbio Limited
• AcceGen Biotechnology Limited Liability Company
• Cell Biologics Incorporated
• BI Biotech India Private Limited
• Innoprot Sociedad Limitada
• ZenBio Incorporated

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ヒト初代細胞培養市場2029：新たな機会を提供する国
• ヒト初代細胞培養市場2029：新たな機会を提供するセグメント
• ヒト初代細胞培養市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Human primary cell culture refers to the process of isolating cells directly from human tissues such as blood or bone marrow and maintaining them in a controlled environment for research or therapeutic use. These cultures offer a more accurate reflection of in vivo biological conditions compared to immortalized cell lines, making them highly valuable for scientific and medical applications.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main product types in human primary cell culture include primary cells, reagents and supplements, instruments, primary cell culture media, and other related products. Primary cells are directly extracted from living tissues and are commonly used in research, drug testing, and various medical studies. Applications of human primary cell culture span drug discovery, therapy development, regenerative medicine, and more. These products and technologies serve a diverse range of end users, including pharmaceutical and biotechnology companies, contract research organizations (CROs), and academic and research institutions.

The human primary cell culture market research report is one of a series of new reports from The Business Research Company that provides human primary cell culture market statistics, including human primary cell culture industry global market size, regional shares, competitors with a human primary cell culture market share, detailed human primary cell culture market segments, market trends and opportunities, and any further data you may need to thrive in the human primary cell culture industry. This human primary cell culture market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The human primary cell culture market size has grown rapidly in recent years. It will grow from $3.39 billion in 2024 to $3.79 billion in 2025 at a compound annual growth rate (CAGR) of 11.7%. The growth during the historic period can be attributed to the increasing adoption of cell-based research, rising demand for personalized medicine, a growing emphasis on drug discovery, an enhanced focus on individualized treatment approaches, and the expanding applications of human primary cell culture in cancer research.

The human primary cell culture market size is expected to see rapid growth in the next few years. It will grow to $5.82 billion in 2029 at a compound annual growth rate (CAGR) of 11.3%. The growth during the forecast period can be attributed to rising investments in regenerative medicine, increased use in precision medicine, growing government funding for cell-based research, enhanced governmental support, and the expanding use of human primary cell culture in toxicology testing. Key trends anticipated in the forecast period include the integration of artificial intelligence (AI) in cell culture analysis, the development of serum-free and chemically defined media, increasing automation in cell culture processes, the emergence of organ-on-a-chip technology, and the growing demand for primary cells in immunotherapy research.

The rising emphasis on cell and gene therapies is anticipated to drive the expansion of the human primary cell culture market. Cell and gene therapies are cutting-edge treatments that involve modifying or replacing genetic material or cells to address diseases at their molecular roots. This growing interest is fueled by the promise of these therapies to offer long-lasting or even curative solutions for genetic disorders, rare diseases, and cancers by targeting their underlying causes. Human primary cell cultures play a vital role in developing these therapies, producing viral vectors, and testing gene-editing approaches. For example, in July 2024, the American Society of Gene & Cell Therapy (ASGCT), a US-based nonprofit organization, reported that 76 gene therapy trials were launched in the United States in Q2 2024 a 25% rise compared to the first quarter. As a result, the increasing focus on cell and gene therapies is accelerating the growth of the human primary cell culture market.

Leading companies in the human primary cell culture market are investing in the development of advanced technologies such as induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs) to boost research capabilities, drug discovery, and regenerative medicine efforts. iPSC and ESC technologies involve reprogramming adult or embryonic cells into pluripotent states, enabling them to differentiate into various cell types for use in scientific research, therapy development, and disease modeling. For instance, in July 2024, BioServe Biotechnologies India Pvt Ltd., an India-based life sciences and biotechnology company, introduced a new range of advanced stem cell products from REPROCELL to support research and drug discovery in India. These offerings include specialized cell culture media, stem cell differentiation kits, 3D culture systems, and drug discovery tools advancing regenerative medicine and preclinical studies powered by iPSC and ESC innovations.

In April 2023, AnaBios Corporation, a US-based contract research organization (CRO), announced the acquisition of Cell Systems Corporation for an undisclosed sum. Through this acquisition, AnaBios seeks to broaden its portfolio of biologically relevant human tissues and primary cells, enhancing research capabilities in cell biology and drug discovery. Cell Systems Corporation, also based in the US, is a provider of human primary cells, specialized cell culture media, and related reagents.

Major players in the human primary cell culture market are Thermo Fisher Scientific Inc., Merck & Co. Inc., Lonza Group AG, STEMCELL Technologies Inc., American Type Culture Collection, PromoCell GmbH, Krishgen Biosystems Private Limited, Cell Culture Company Limited Liability Company, HiMedia Laboratories Private Limited, 3H Biomedical Aktiebolag, ScienCell Research Laboratories Inc., Cell Applications Incorporated, Life Technologies Private Limited, PELOBIOTECH Gesellschaft mit beschrankter Haftung, Amsbio Limited, AcceGen Biotechnology Limited Liability Company, Cell Biologics Incorporated, BI Biotech India Private Limited, Innoprot Sociedad Limitada, ZenBio Incorporated, Evercyte GmbH, Cell Systems Corporation, Cytion GmbH, Kosheeka Private Limited.

North America was the largest region in the human primary cell culture market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in human primary cell culture report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the human primary cell culture market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The human primary cell culture market consists of revenues earned by entities by providing services such as cell isolation, culture media development, cryopreservation, cell characterization, and quality control testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The human primary cell culture market also includes sales of culture media, reagents, bioreactors, incubators, cell storage systems, and imaging systems used in regenerative medicine. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Human Primary Cell Culture Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on human primary cell culture market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for human primary cell culture ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The human primary cell culture market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Primary Cells; Reagents And Supplements; Instruments; Primary Cell Culture Media; Other Consumables
• 2) By Applications: Drug Discovery; Therapy Development; Regenerative Medicine; Other Applications
• 3) By End User: Pharmaceutical And Biotechnology Companies; Contract Research Organizations (CROs); Academic And Research Institutions
• Subsegments:
• 1) By Primary Cells: Human Dermal Fibroblasts (HDF); Human Epidermal Keratinocytes (HEK); Human Mesenchymal Stem Cells (HMSC); Human Endothelial Cells; Human Hematopoietic Cells
• 2) By Reagents And Supplements: Growth Factors And Cytokines; Antibiotics And Antimycotics; Fetal Bovine Serum (FBS); Buffers And Chemicals; Cryopreservation Reagents
• 3) By Instruments: Cell Culture Incubators; Biosafety Cabinets; Centrifuges; Cell Counters And Analyzers; Microscopes
• 4) By Primary Cell Culture Media: Serum-Free Media; Chemically Defined Media; Classical Media; Protein-Free Media; Custom Media
• 5) By Other Consumables: Culture Dishes And Plates; Flasks And Bottles; Pipettes And Tips; Cell Strainers And Filters; Coated Culture Surfaces
• Companies Mentioned: Thermo Fisher Scientific Inc.; Merck & Co. Inc.; Lonza Group AG; STEMCELL Technologies Inc.; American Type Culture Collection
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Human Primary Cell Culture Market Characteristics

3. Human Primary Cell Culture Market Trends And Strategies

4. Human Primary Cell Culture Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Human Primary Cell Culture Growth Analysis And Strategic Analysis Framework

• 5.1. Global Human Primary Cell Culture PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Human Primary Cell Culture Market Growth Rate Analysis
• 5.4. Global Human Primary Cell Culture Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Human Primary Cell Culture Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Human Primary Cell Culture Total Addressable Market (TAM)

6. Human Primary Cell Culture Market Segmentation

• 6.1. Global Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Primary Cells
• Reagents And Supplements
• Instruments
• Primary Cell Culture Media
• Other Consumables
• 6.2. Global Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Discovery
• Therapy Development
• Regenerative Medicine
• Other Applications
• 6.3. Global Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical And Biotechnology Companies
• Contract Research Organizations (CROs)
• Academic And Research Institutions
• 6.4. Global Human Primary Cell Culture Market, Sub-Segmentation Of Primary Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Human Dermal Fibroblasts (HDF)
• Human Epidermal Keratinocytes (HEK)
• Human Mesenchymal Stem Cells (HMSC)
• Human Endothelial Cells
• Human Hematopoietic Cells
• 6.5. Global Human Primary Cell Culture Market, Sub-Segmentation Of Reagents And Supplements, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Growth Factors And Cytokines
• Antibiotics And Antimycotics
• Fetal Bovine Serum (FBS)
• Buffers And Chemicals
• Cryopreservation Reagents
• 6.6. Global Human Primary Cell Culture Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cell Culture Incubators
• Biosafety Cabinets
• Centrifuges
• Cell Counters And Analyzers
• Microscopes
• 6.7. Global Human Primary Cell Culture Market, Sub-Segmentation Of Primary Cell Culture Media, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Serum-Free Media
• Chemically Defined Media
• Classical Media
• Protein-Free Media
• Custom Media
• 6.8. Global Human Primary Cell Culture Market, Sub-Segmentation Of Other Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Culture Dishes And Plates
• Flasks And Bottles
• Pipettes And Tips
• Cell Strainers And Filters
• Coated Culture Surfaces

7. Human Primary Cell Culture Market Regional And Country Analysis

• 7.1. Global Human Primary Cell Culture Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Human Primary Cell Culture Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Human Primary Cell Culture Market

• 8.1. Asia-Pacific Human Primary Cell Culture Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Human Primary Cell Culture Market

• 9.1. China Human Primary Cell Culture Market Overview
• 9.2. China Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Human Primary Cell Culture Market

• 10.1. India Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Human Primary Cell Culture Market

• 11.1. Japan Human Primary Cell Culture Market Overview
• 11.2. Japan Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Human Primary Cell Culture Market

• 12.1. Australia Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Human Primary Cell Culture Market

• 13.1. Indonesia Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Human Primary Cell Culture Market

• 14.1. South Korea Human Primary Cell Culture Market Overview
• 14.2. South Korea Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Human Primary Cell Culture Market

• 15.1. Western Europe Human Primary Cell Culture Market Overview
• 15.2. Western Europe Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Human Primary Cell Culture Market

• 16.1. UK Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Human Primary Cell Culture Market

• 17.1. Germany Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Human Primary Cell Culture Market

• 18.1. France Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Human Primary Cell Culture Market

• 19.1. Italy Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Human Primary Cell Culture Market

• 20.1. Spain Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Human Primary Cell Culture Market

• 21.1. Eastern Europe Human Primary Cell Culture Market Overview
• 21.2. Eastern Europe Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Human Primary Cell Culture Market

• 22.1. Russia Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Human Primary Cell Culture Market

• 23.1. North America Human Primary Cell Culture Market Overview
• 23.2. North America Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Human Primary Cell Culture Market

• 24.1. USA Human Primary Cell Culture Market Overview
• 24.2. USA Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Human Primary Cell Culture Market

• 25.1. Canada Human Primary Cell Culture Market Overview
• 25.2. Canada Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Human Primary Cell Culture Market

• 26.1. South America Human Primary Cell Culture Market Overview
• 26.2. South America Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Human Primary Cell Culture Market

• 27.1. Brazil Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Human Primary Cell Culture Market

• 28.1. Middle East Human Primary Cell Culture Market Overview
• 28.2. Middle East Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Human Primary Cell Culture Market

• 29.1. Africa Human Primary Cell Culture Market Overview
• 29.2. Africa Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Human Primary Cell Culture Market Competitive Landscape And Company Profiles

• 30.1. Human Primary Cell Culture Market Competitive Landscape
• 30.2. Human Primary Cell Culture Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. STEMCELL Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. American Type Culture Collection Overview, Products and Services, Strategy and Financial Analysis

31. Human Primary Cell Culture Market Other Major And Innovative Companies

• 31.1. PromoCell GmbH
• 31.2. Krishgen Biosystems Private Limited
• 31.3. Cell Culture Company Limited Liability Company
• 31.4. HiMedia Laboratories Private Limited
• 31.5. 3H Biomedical Aktiebolag
• 31.6. ScienCell Research Laboratories Inc.
• 31.7. Cell Applications Incorporated
• 31.8. Life Technologies Private Limited
• 31.9. PELOBIOTECH Gesellschaft mit beschrankter Haftung
• 31.10. Amsbio Limited
• 31.11. AcceGen Biotechnology Limited Liability Company
• 31.12. Cell Biologics Incorporated
• 31.13. BI Biotech India Private Limited
• 31.14. Innoprot Sociedad Limitada
• 31.15. ZenBio Incorporated

32. Global Human Primary Cell Culture Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Human Primary Cell Culture Market

34. Recent Developments In The Human Primary Cell Culture Market

35. Human Primary Cell Culture Market High Potential Countries, Segments and Strategies

• 35.1 Human Primary Cell Culture Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Human Primary Cell Culture Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Human Primary Cell Culture Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250617_r34874_Human_Primary_Cell_Culture_GMR_2025